Paul I Terasaki (10 September, 1929-25 January, 2016)
Process of allogeneic hematopoietic cell transplantation decision making for older adults
Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network
Prophylactic donor lymphocyte infusion in patients with high-risk acute myeloid leukemia: ready for prime time?
Hematopoietic cell transplantation in older adults: deciding or decision-making?
Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas
Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation
TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia
Consideration of noninherited maternal Ags as permissible HLA mismatches in cord blood donor selection
Adverse reactions during stem cell infusion in children treated with autologous and allogeneic stem cell transplantation
Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI
Conjunctival polyploid cells and donor-derived myofibroblasts in ocular GvHD
Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis
Prevalence and determinants of fatigue in patients with moderate to severe chronic GvHD
Risk factors for recurrent Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients
Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood
Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation
Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality
Extracorporeal photopheresis as a new supportive therapy for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation
Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy
Treatment of hepatitis C in a pediatric patient using simeprevir and sofosbuvir immediately after an umbilical cord blood transplantation
Early changes in bone mineral density and trabecular bone score following allogeneic stem cell transplant
Phosphorylated STAT3 expression in hematopoietic stem cell transplant-associated large granular lymphocytic leukemia
Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita
Astrovirus outbreak at a pediatric hematology and hematopoietic stem cell transplant unit despite strict hygiene rules
Is allogeneic transplant for solid tumors still alive?
TCR αβ and CD19-depleted haploidentical stem cell transplant with reduced intensity conditioning for Hoyeraal-Hreidarsson syndrome with RTEL1 mutation